Silverback Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Silverback Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Silverback Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Silverback Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $649k | 119k | 5.48 |
| 2023-09-30 | $666k | 176k | 3.78 |
| 2023-06-30 | $1.9M | 284k | 6.70 |
| 2023-03-31 | $551k | 85k | 6.51 |
| 2022-12-31 | $409k | 48k | 8.53 |
| 2022-06-30 | $1.6M | 381k | 4.24 |
| 2022-03-31 | $685k | 195k | 3.51 |
| 2021-12-31 | $623k | 94k | 6.66 |
| 2021-09-30 | $743k | 75k | 9.97 |
| 2021-06-30 | $1.1M | 35k | 30.88 |
| 2020-12-31 | $6.9M | 138k | 50.00 |